RaySearch Laboratories AB (publ) announces the launch of RayStation 12A, the latest version of the company’s advanced treatment planning system

July 25, 2022 —  RaySearch Laboratories AB announces the launch of RayStation* 12A, the latest version of the company’s advanced treatment planning system. Version 12A includes innovative new features in addition to several general enhancements. 

Deep Learning Segmentation for All Users

With the release of RayStation 12A, deep learning segmentation is available for everyone that is using RayStation for patient modeling. New and updated segmentation models will be released on a regular basis. The segmentation models can be linked to segmentation templates and protocols and used to tailor fast and automated segmentation for different body sites and diagnoses.  

Brachy Planning for Elekta Afterloaders

RayStation 12A supports brachy planning for Elekta Flexitron afterloaders. The dedicated brachy planning module allows rapid creation of optimal and accurate high-dose rate brachytherapy treatment plans. Automatic tools can be used to efficiently reconstruct the applicator and its channels. With RayStation’s powerful optimization tools, optimal dwell time distributions can be obtained within seconds. 

Other highlights of RayStation 12A include robust evaluation on multiple images, new and much faster electron Monte Carlo dose engine, and improvements for CyberKnife planning. 

Johan Löf, founder and CEO, RaySearch, says: “Making deep learning segmentation available to all users will substantially reduce time for contouring of organs and is a good example of our ambition to automate the treatment planning process.” 

* Subject to regulatory clearance in some markets. 

For more information: www.raysearchlabs.com

Related Content

Feature | Radiology Business | By Melinda Taschetta-Millane

Did you know that Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from ...

Time August 12, 2022
arrow
News | ASTRO

August 12, 2022 — The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joseph R ...

Time August 12, 2022
arrow
News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

Time August 09, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
News | Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

Time August 04, 2022
arrow
News | Pediatric Imaging

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

Time August 03, 2022
arrow
Subscribe Now